Members of a House subcommittee don't doubt whether FDA's OTC drug monograph program needs changes, but several want to know what took the agency so long to ask for help.
The Energy and Commerce Committee's Health subcommittee heard testimony on Sept. 13 from FDA drug center chief Janet Woodcock and...